logo

Mustang Bio Inc (MBIO)



Trade MBIO now with
  Date
  Headline
9/23/2019 8:34:25 AM Mustang Bio: City Of Hope Opens And Beginning To Treat Its First Patients In Phase 1 Clinical Trial Of MB-105
3/18/2019 7:37:45 AM Mustang Bio FY Loss Attributable To Stockholders $30.7 Mln Or $1.14/Shr Vs Loss $31.3 Mln Or $1.24/Shr Last Year
12/20/2018 8:34:56 AM Mustang Bio Gets Orphan Drug Designation For MB-102 For Blastic Plasmacytoid Dendritic Cell Neoplasm
11/28/2018 8:08:56 AM Mustang Bio Reports Presentation Of MB-102 Safety And Efficacy Data At AACR Special Conference
10/15/2018 8:05:27 AM Mustang Bio Appoints Martina Sersch As Chief Medical Officer
7/19/2018 8:35:46 AM Mustang Bio Completes Pre-IND Meeting With FDA For MB-102 (CD123 CAR T)
6/22/2018 8:01:48 AM Mustang Bio Announces Opening Of CAR T Cell Therapy Manufacturing Facility In Worcester, Mass
5/30/2018 7:38:53 AM Mustang Bio Reports Preclinical Data On Potency Of Its CAR T Cells In Glioblastoma Published In JCI Insight
3/15/2018 7:32:48 AM Mustang Bio Names Sadik Kassim Chief Scientific Officer And Knut Niss Chief Technology Officer
  
 
>